Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A
Abbreviations
Abdominal Wound Infection
aciclovir
     breastfeeding
     encephalitis
     herpes simplex
     OAT (transporter)
     OATP (transporter)
     renal impairment
     shingles
Adverse Drug Reactions
     Adverse Drug Reaction (ADR) Reporting Guidelines
     Assessing Adverse Drug Reactions
Allergic Disorders
     penicillin allergy
allopurinol
     renal impairment
     xanthine oxidase
amantadine
     anticholinergic
     renal impairment
Aminoglycosides
     dosing guidelines
          Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
          Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
     renal impairment
     therapeutic drug monitoring
amiodarone
     breastfeeding
     CYP1A2
     CYP2C8/9
     CYP3A
     drug-drug interactions
     P-glycoprotein
     QT prolongation
     therapeutic drug monitoring
amisulpride
     anticholinergic
amitriptyline
     anticholinergic
     CYP2D6
     serotonergic
amlodipine
     CYP3A
amoxicillin
     acute peritonitis
     bacterial endocarditis prophylaxis
     breastfeeding
     cellulitis
     cholecystitis/cholangitis
     COPD exacerbations
          Empiric
          Pathogens Known
     cystitis
     H. pylori eradication
     IV to oral
     meningitis
     pneumonia
          Empiric
          Pathogens Known
     post-op urosepsis
     pyelonephritis
     sinusitis
amoxicillin/clavulanate
     acute epiglottitis
     acute peritonitis
     bites
     cellulitis
     cholecystitis/cholangitis
     COPD exacerbations
          Empiric
          Pathogens Known
     cystitis
     deep neck space infections
     IV to oral
     mastitis
     pneumonia
          Empiric
          Hospital-acquired Pneumonia
          Pathogens Known
     post-op abdominal wound infection
     prostatitis
     sinusitis
          Acute Rhinosinusitis
          Chronic Rhinosinusitis
     surgical prophylaxis
Angiotensin-2 Receptor Antagonists
     CYP2C8/9
Anti-Arrhythmics
     CYP2D6
Anticholinergic toxicity
Anticoagulants
     drug-drug interactions
Antidepressants
     anticholinergic
     breastfeeding
     CYP2D6
     drug-drug interactions
     elderly
     liver impairment
     pregnancy
     QT prolongation
     serotonergic
Antiepileptics
     drug-drug interactions
Antifungals
     candidal vulvovaginitis
     CYP3A
     drug-drug interactions
     therapeutic drug monitoring
Antihistamines
     anticholinergic
     breastfeeding
Antihypertensives
     drug and food interactions
     pregnancy
Antimicrobial advice and allergy
     General Antimicrobial Advice
     Penicillin Allergy
Antimicrobial Guidelines
Antimicrobial IV to oral switch
Antipsychotics
     CYP2D6
     liver impairment
Antivirals
     influenza
aripiprazole
     anticholinergic
     CYP2D6
     CYP3A
atenolol
     renal impairment
atomoxetine
     CYP2D6
atorvastatin
     CYP3A
azathioprine
     dosing guideline
     drug-drug interactions
     pharmacogenetics
     prodrugs and dosing
     therapeutic drug monitoring
azithromycin
     breastfeeding
     chlamydia
     conjunctivitis
     CYP3A
     diarrhoea
     gonorrhoea
     pelvic inflammatory disease
     pertussis
     pneumonia
          Empiric
          Pathogens Known
     QT prolongation
     urethritis (non-gonococcal)
B
baclofen
     anticholinergic
     renal impairment
Bacteraemia (MRSA guideline)
Bacterial Endocarditis
     prophylaxis
     treatment
Bacterial Vaginosis
Benzodiazepines
     breastfeeding
     CYP3A
     elderly
     glucuronidation
benztropine
     anticholinergic
benzylpenicillin (Penicillin G)
     acute peritonitis
     bacterial endocarditis
     cellulitis
     group A strep (with MRSA)
     group B streptococcus prophylaxis
     IV to oral
     meningitis
     necrotising soft tissue infection
     osteomyelitis/septic arthritis
Beta-2-Adrenoceptor Stimulants
     conjugation
Beta-Adrenoceptor Blocking Drugs
     breastfeeding
     CYP2D6
     CYP3A
bezafibrate
     CYP3A
Bile sequestrants (PML)
     drug and food interactions
Bites
Bone and Joint Infections
Breastfeeding – prescribing in
bupropion
     CYP2D6
buspirone
     CYP3A
     serotonergic
C
calcium
     drug and food interactions
Calcium Channel Blockers
     breastfeeding
     CYP3A
candesartan
     CYP2C8/9
     renal impairment
Candidal Vulvovaginitis
carbamazepine
     anticholinergic
     breastfeeding
     conjugation
     CYP2C19
     CYP3A
     drug and food interactions
     pharmacogenetics
     pregnancy
     serotonergic
     therapeutic drug monitoring
Carbapenems
     penicillin allergy
     renal impairment
carbimazole
     pregnancy
Cardiovascular System
     Antimicrobial guidelines
carvedilol
     CYP2D6
     P-glycoprotein
cefalexin
     breastfeeding
     cellulitis
     cystitis
     deep neck space infections
     mastitis
     osteomyelitis/septic arthritis
     pyelonephritis
cefazolin
     bacterial endocarditis
     cellulitis
     group B streptococcus prophylaxis
     MRSA guideline
     necrotising soft tissue infection
     osteomyelitis/septic arthritis
     pneumonia
     post-op septicaemia
     probenecid
     pyomyositis
     surgical prophylaxis
cefotaxime
     acute peritonitis
ceftriaxone
     acute epiglottitis
     breastfeeding
     deep neck space infections
     diarrhoea - infection associated
     gonorrhoea
     meningitis
     necrotising soft tissue infection
     pelvic inflammatory disease
     penicillin allergy
     pneumonia
     pyelonephritis
     renal impairment
     septicaemia
cefuroxime
     acute epiglottitis
     acute peritonitis
     bites
     cellulitis
     cholecystitis/cholangitis
     COPD exacerbations
          Empiric
          Pathogens Known
     penicillin allergy
     pneumonia
          Empiric
          Hospital-acquired Pneumonia
          Pathogens Known
     post-op abdominal wound infection
     post-op septicaemia
     prostatitis
     septicaemia
     surgical prophylaxis
celiprolol
     P-glycoprotein
Cellulitis
     complicated/ulcers
     post-op
     simple
Central Nervous System
     Antimicrobial Guidelines
Cephalosporins
     breastfeeding
     OAT (transporter)
     penicillin allergy
     renal impairment
cervicitis
     Chlamydial Cervicitis / Urethritis / Proctitis
     Gonorrhoea
cetirizine
     anticholinergic
     OCT (transporter)
     renal impairment
Charting
chloramphenicol
     conjugation
     conjunctivitis
     CYP2C19
chlorhexidine
     MRSA guideline
chlorpromazine
     anticholinergic
     breastfeeding
     CYP2D6
Cholecystitis/Cholangitis
cholestyramine
     drug and food interactions
ciclosporin
     CYP3A
     OAT (transporter)
     OATP (transporter)
     P-glycoprotein
     therapeutic drug monitoring
cigarette smoking
     CYP1A2
cilazapril
     renal impairment
ciprofloxacin
     breastfeeding
     CYP1A2
     CYP3A
     diarrhoea - infection associated
     epiglottitis
     gonorrhoea
     IV to oral
     meningitis
     OAT (transporter)
     OATP (transporter)
     prostatitis
     pyelonephritis
     sinusitis
citalopram
     breastfeeding
     QT prolongation
     serotonergic
clarithromycin
     breastfeeding
     CYP2C19
     CYP3A
     drug-drug interactions
     H. pylori eradication
     IV to oral
     pneumonia
     QT prolongation
clindamycin
     bacterial endocarditis prophylaxis
     bites
     cellulitis
          Cellulitis - Simple and Erysipelas
          Infected Ulcers (e.g. diabetic, vascular, pressure)
     deep neck space infections
     epiglottitis
     mastitis
     MRSA
     necrotising soft tissue infection
     pelvic inflammatory disease
     pneumonia
     post-op abdominal wound infection
     surgical prophylaxis
clomipramine
     anticholinergic
     CYP1A2
     CYP2D6
     serotonergic
clonazepam
     CYP3A
clopidogrel
     CYP2C19
     pharmacogenetics
     prodrugs and dosing
clotrimazole
     candidal vulvovaginitis
clozapine
     anticholinergic
     CYP1A2
     therapeutic drug monitoring
codeine
     anticholinergic
     CYP2D6
     drug-drug interactions
     pharmacogenetics
     prodrugs and dosing
colchicine
     P-glycoprotein
Conjugation
Conjunctivitis
COPD exacerbations
     Empiric
     Pathogens Known
Corticosteroids
     CYP3A
     meningitis
cyclophosphamide
     CYP2C19
Cystitis
Cytochrome P450 1A2 (CYP1A2)
Cytochrome P450 2C19 (CYP2C19)
Cytochrome P450 2C8/9 (CYP2C8/9)
Cytochrome P450 2D6 (CYP2D6)
Cytochrome P450 3A (CYP3A)
D
dabigatran etexilate
     drug-drug interactions
     PgP
     renal impairment
dalteparin
     renal impairment
Deep neck space infections
dexamethasone
     CYP3A
     meningitis
Diarrhoea
     antimicrobial associated
     infection associated
diazepam
     CYP2C19
     CYP3A
diclofenac
     breastfeeding
     CYP2C8/9
digoxin
     anticholinergic
     breastfeeding
     P-glycoprotein
     renal impairment
     therapeutic drug monitoring
dihydrocodeine
     CYP2D6
diltiazem
     breastfeeding
     CYP3A
     P-glycoprotein
Discharge Prescribing
Diuretics
     drug and food interactions
domperidone
     breastfeeding
     CYP3A
     QT prolongation
doxazosin
     CYP3A
doxepin
     anticholinergic
     CYP2D6
     serotonergic
doxycycline
     bites
     breastfeeding
     chlamydia
     COPD exacerbations
          Empiric
          Pathogens Known
     mastitis
     pelvic inflammatory disease
     pneumonia
          Empiric
          Pathogens Known
     sinusitis
          Acute Rhinosinusitis
          Chronic Rhinosinusitis
Drug - food interaction
Drug Concentration Monitoring
Drug Information Service (DIS)
Drug Profile Tables
Drug Profiles
Drug-drug interaction
E
Ear, Nose & Oropharynx
     Antimicrobial guidelines
eformoterol
     glucuronidation
Elderly - prescribing in
enalapril
     renal impairment
Encephalitis
enoxaparin
     breastfeeding
     renal impairment
entacapone
     anticholinergic
     glucuronidation
Epidural abscess
Epiglottitis
erythromycin
     breastfeeding
     CYP3A
     drug-drug interactions
     pelvic inflammatory disease
     P-glycoprotein
     QT prolongation
escitalopram
     breastfeeding
     QT prolongation
     serotonergic
ethambutol
     renal impairment
Eye
     Antimicrobial guidelines
ezetimibe
     glucuronidation
F
felodipine
     CYP3A
fentanyl
     CYP3A
finasteride
     CYP3A
flecainide
     CYP2D6
     QT prolongation
     therapeutic drug monitoring
flucloxacillin
     bacteraemia (MRSA guideline)
     bacterial endocarditis
     cellulitis
     IV to oral
     mastitis
     necrotising soft tissue infection
     osteomyelitis/septic arthritis
     pneumonia
     post-op abdominal wound infection
     post-op septicaemia
     probenecid
     pyomyositis
     sinusitis
          Acute Rhinosinusitis
          Chronic Rhinosinusitis
fluconazole
     candidal vulvovaginitis
     CYP2C19
     CYP2C8/9
     CYP3A
     renal impairment
fludrocortisone
     CYP3A
fluoxetine
     CYP2C19
     CYP2D6
     serotonergic
flutamide
     CYP1A2
     CYP3A
Food and Drug Interactions
fosfomycin
     cystitis
frusemide
     OAT (transporter)
furosemide
     OAT (transporter)
G
gabapentin
     renal impairment
Gastrointestinal System
     Antimicrobial guidelines
gentamicin
     acute peritonitis
     bacterial endocarditis
     cellulitis
     cholecystitis/cholangitis
     dosing guidelines
          Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
          Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
     IV to oral
     necrotising soft tissue infection
     pelvic inflammatory disease
     pneumonia
          Empiric
          Hospital-acquired Pneumonia
     post-op abdominal wound infection
     post-op limb wound infection
     post-op pneumonia
     post-op septicaemia
     post-op urosepsis
     prostatitis
     pyelonephritis
     renal impairment
     septicaemia
     surgical prophylaxis
     therapeutic drug monitoring
Gentamicin/Tobramycin Dosing
     Gentamicin/Tobramycin Dosing Guidelines (Adults)
     Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
glibenclamide
     CYP2C8/9
     OATP (transporter)
gliclazide
     CYP2C8/9
glipizide
     CYP2C8/9
Glucuronidation
Gonorrhoea
Group B streptococcus prophylaxis
H
H. pylori eradication
haloperidol
     anticholinergic
     CYP2D6
     CYP3A
heparin
     breastfeeding
Herpes Simplex
     encephalitis
     orofacial/genital
HIV
     CYP3A
     P-glycoprotein
hyoscine (PML)
     anticholinergic
I
ibuprofen
     CYP2C8/9
imipenem/cilastatin
     renal impairment
imipramine
     anticholinergic
     CYP2C19
     CYP2D6
     serotonergic
Immunosuppressants
     breastfeeding
     CYP3A
     P-glycoprotein
Influenza
Insulins
     breastfeeding
     metabolism
Intravenous to oral antimicrobials
Introduction
     Aspects of Individualising Drug Therapy
     Pink Book
isoniazid
     conjugation
     CYP2C19
     CYP2C8/9
isotretinoin
     breastfeeding
     pregnancy
itraconazole
     CYP3A
     P-glycoprotein
     therapeutic drug monitoring
K
ketoconazole
     CYP1A2
     CYP2C19
     CYP2C8/9
     CYP3A
     P-glycoprotein
L
labetalol
     breastfeeding
lamivudine
     renal impairment
lamotrigine
     glucuronidation
     pregnancy
     therapeutic drug monitoring
lansoprazole
     CYP2C19
Laxatives (PML)
     drug and food interactions
levetiracetam
     renal impairment
levodopa/benserazide
     anticholinergic
levodopa/carbidopa
     anticholinergic
lignocaine
     CYP2D6
     CYP3A
     liver impairment
Limb wound infection - post-op
lithium
     breastfeeding
     Drug-drug interaction
     pregnancy
     QT prolongation
     renal impairment
     serotonergic
     therapeutic drug monitoring
Liver impairment- prescribing in
loperamide
     anticholinergic
     CYP3A
     P-glycoprotein
loratadine
     anticholinergic
     breastfeeding
     CYP3A
lorazepam
     glucuronidation
losartan
     CYP2C8/9
M
Macrolides
     CYP3A
     drug-drug interactions
     QT prolongation
Mastitis / Breast Abscess
Meningitis
6-mercaptopurine
     dosing guideline
     pharmacogenetics
     prodrugs and dosing
     Therapeutic Drug Monitoring
meropenem
     pneumonia
     post-op pneumonia
     post-op septicaemia
     renal impairment
     septicaemia
mesalazine
     breastfeeding
Metabolism - drugs
metformin
     breastfeeding
     OCT (transporter)
     renal impairment
methadone
     CYP3A
     QT prolongation
methotrexate
     pregnancy
     renal impairment
methyldopa
     breastfeeding
methylprednisolone
     CYP3A
metoclopramide
     anticholinergic
     CYP2D6
metoprolol
     breastfeeding
     CYP2D6
     drug and food interactions
metronidazole
     acute peritonitis
     bacterial vaginosis
     bites
     cellulitis
     cholecystitis/cholangitis
     deep neck space infections
     diarrhoea - antimicrobial associated
     H. pylori eradication
     IV to oral
     parasitic GI infection
     pelvic inflammatory disease
     post-op abdominal wound
     post-op septicaemia
     septicaemia
     surgical prophylaxis
     trichomoniasis
midazolam
     breastfeeding
     CYP3A
mirtazapine (PML)
     anticholinergic
     serotonergic
moclobemide
     breastfeeding
     CYP2C19
     CYP2D6
     drug and food interactions
     serotonergic
Monoamine-Oxidase Inhibitors (PML)
     serotonergic
morphine
     breastfeeding
     glucuronidation
     P-glycoprotein
     renal dysfunction
MRSA
     bacteraemia
     co-infection with group A strep
     decolonization
     soft tissue infection
mupirocin
     MRSA guideline
mycophenolate
     glucuronidation
     therapeutic drug monitoring
N
nadolol
     renal impairment
naloxone
     glucuronidation
naproxen
     CYP2C8/9
Necrotising soft tissue infection
nifedipine
     CYP3A
     P-glycoprotein
nitazoxanide
     parasitic GI infection
Nitrates
     liver impairment
nitrofurantoin
     breastfeeding
     cystitis
Non Steroidal Anti-inflammatory Drugs (NSAIDs)
     breastfeeding
     drug-drug interactions
     elderly
     liver impairment
     pregnancy
norfloxacin
     breastfeeding
     cystitis
nortriptyline
     anticholinergic
     breastfeeding
     CYP2D6
     serotonergic
nystatin
     candidal vulvovaginitis
O
OAT (transporter)
OATP (transporter)
Obese - prescribing in
Obstetrics, Gynaecology (Antimicrobial Guidelines)
OCT (transporter)
oestradiol
     CYP3A
olanzapine
     anticholinergic
     CYP1A2
omeprazole
     CYP2C19
     H. pylori eradication
ondansetron
     CYP2D6
Opioids
     drug and food interactions
     glucuronidation
     liver impairment
     pregnancy
ornidazole
     bacterial vaginosis
     parasitic GI infection
     trichomoniasis
oseltamivir
     influenza
     renal impairment
Osteomyelitis/septic arthritis
oxazepam
     glucuronidation
oxybutynin
     anticholinergic
oxycodone
     breastfeeding
P
pantoprazole
     CYP2C19
paracetamol
     breastfeeding
     glucuronidation
     liver impairment
Parasitic GI infection
paroxetine
     anticholinergic
     breastfeeding
     CYP2D6
     serotonergic
Pelvic Inflammatory Disease
Penicillins
     allergy
     OAT (transporter)
     renal impairment
perhexiline
     CYP2D6
     pharmacogenetics
     therapeutic drug monitoring
Peritonitis - acute
Pertussis
P-glycoprotein
Pharmacogenetics
Pharmacology Guidelines
Pharyngitis
phenoxymethylpenicillin (Penicillin V)
     cellulitis
     group A strep (with MRSA)
     IV to oral
     pharyngitis
phenytoin
     breastfeeding
     CYP1A2
     CYP2C19
     CYP2C8/9
     CYP3A
     glucuronidation
     pregnancy
     therapeutic drug monitoring
piperacillin/tazobactam (Tazocin™)
     pneumonia
     post-op pneumonia
     post-op septicaemia
     septicaemia
pizotifen
     glucuronidation
Pneumonia
     community-acquired
     hospital-acquired
     post-op
Polypharmacy toxicities - common
pramipexol
     anticholinergic
     renal dysfunction
     transporter
prednisolone
     CYP3A
prednisone
     breastfeeding
Pregnancy – prescribing in
Prescribing Instructions
probenecid
     cefazolin
     flucloxacillin
     OAT (transporter)
     OATP (transporter)
prochlorperazine
     anticholinergic
procyclidine
     anticholinergic
Prodrugs and dosing
Progestogens
     breastfeeding
     CYP3A
     P-glycoprotein
promethazine
     anticholinergic
     CYP2D6
propranolol
     breastfeeding
     CYP2D6
     CYP3A
Prostatitis
Pyelonephritis
Pyomyositis
Q
QT prolongation
quetiapine
     anticholinergic
     CYP3A
quinapril
     breastfeeding
     renal impairment
Quinolones
     breastfeeding
     CYP1A2
     drug and food interactions
R
ranitidine
     anticholinergic
     breastfeeding
     flavin monooxygenase
     renal impairment
Renal impairment - prescribing in
Respiratory System
     Antimicrobial guidelines
rifampicin
     CYP1A2
     CYP2C19
     CYP2C8/9
     CYP3A
     Drug-drug interaction
     glucuronidation
     OAT (transporter)
     OATP (transporter)
     P-glycoprotein
risperidone
     anticholinergic
     CYP2D6
     CYP3A
ropinirole
     anticholinergic
     CYP1A2
Routes of Administration
roxithromycin
     breastfeeding
     CYP3A
     IV to oral
     P-glycoprotein
     pharyngitis
     QT prolongation
     sinusitis
          Acute Rhinosinusitis
          Chronic Rhinosinusitis
S
salbutamol
     conjugation
     pregnancy
salmeterol
     conjugation
selegiline
     anticholinergic
     CYP2C19
senna
     drug and food interactions
Septic Arthritis
Septicaemia
Serotonin toxicity
sertraline
     CYP2D6
     serotonergic
Sexually transmitted diseases
Shingles
simvastatin
     CYP3A
     drug and food interactions
     P-glycoprotein
Sinusitis
     Acute Rhinosinusitis
     Chronic Rhinosinusitis
Skin
     Antimicrobial guidelines
solifenacin
     anticholinergic
sotalol
     QT prolongation
     renal impairment
SSRIs
     serotonergic
Statins
     CYP3A
     liver impairment
Steroids
     CYP3A
     meningitis
Stimulant laxatives
     drug and food interactions
sumatriptan
     serotonergic
Surgical Post-Operative Antimicrobials
Surgical Prophylaxis Antimicrobials
Syphilis
T
tacrolimus
     CYP3A
     P-glycoprotein
     therapeutic drug monitoring
tamoxifen
     CYP2D6
     P-glycoprotein
     pharmacogenetics
     prodrugs and dosing
teicoplanin
temazepam
     glucuronidation
terbinafine
     CYP2D6
testosterone
     CYP3A
Tetracyclines
     breastfeeding
     drug and food interactions
     pregnancy
theophylline
     CYP1A2
     drug-drug interactions
     therapeutic drug monitoring
Therapeutic Drug Monitoring
ticagrelor
     CYP3A
timolol
     CYP2D6
tobramycin
     dosing guidelines
          Antimicrobial Dosing Guidelines (Adults) – Gentamicin/Tobramycin and Vancomycin
          Gentamicin/Tobramycin Dosing in Patients with Spinal Injuries (Adults)
     renal impairment
     therapeutic drug monitoring
tolterodine
     CYP2D6
topiramate
     renal impairment
tramadol
     CYP2D6
     serotonergic
tranexamic acid
     renal impairment
Transport - drugs
Trichomoniasis
Tricyclic Antidepressants
     breastfeeding
     elderly
     QT prolongation
     serotonergic
trimethoprim
     breastfeeding
     cystitis
     pyelonephritis
     renal impairment
trimethoprim/sulfamethoxazole (co-trimoxazole)
     bites
     breastfeeding
     conjugation
     CYP2C8/9
     diarrhoea - infection associated
     meningitis
     MRSA soft tissue infection
     parasitic GI infection
     pertussis
     prostatitis
     renal impairment
U
Urethritis
     Chlamydial Cervicitis / Urethritis / Proctitis
     Gonorrhoea
     Non-Gonococcal Urethritis
Urinary Tract Infections
Urosepsis - post-op
V
valproate
     breastfeeding
     glucuronidation
     pregnancy
     serotonergic
     therapeutic drug monitoring
vancomycin
     bacterial endocarditis
     bacterial endocarditis prophylaxis
     diarrhoea - antimicrobial associated
     dosing guidelines
          Continuous Infusions
          Vancomycin Dosing Guidelines (Adults)
     Group B streptococcus prophylaxis
     meningitis
     MRSA
     osteomyelitis/septic arthritis
     pneumonia
          Empiric
          Pathogens Known
     renal impairment
     surgical prophylaxis
     therapeutic drug monitoring
varenicline
     OCT (transporter)
Varicella zoster
venlafaxine
     anticholinergic
     breastfeeding
     CYP2D6
     serotonergic
verapamil
     CYP3A
     P-glycoprotein
Vitamin A
     pregnancy
Vitamin D
     drug and food interactions
Vitamin K
     drug and food interactions
     liver impairment
voriconazole
     CYP2C8/9
     CYP3A
     therapeutic drug monitoring
W
warfarin
     anticholinergic
     breastfeeding
     CYP2C8/9
     drug and food interactions
     drug-drug interactions
     pharmacogenetics
     pregnancy
Z
ziprasidone
     CYP3A